Overall, our quantitative analysis showed that, compared to control tumors (bratIR; mCherryIR), depleting upregulated metabolic transporters led to a significant reduction in tumor volume, except for the amino acid transporter path, Eaat1, and the carbohydrate transporter CG10960 (Fig. 1D). The gene discussed is SLC1A3; the disease is neoplasm.